Bryan is a scientist in the Molecular Oncology group at Kadmon Corporation and utilizes a variety of biochemical and structural biology approaches in advancing preclinical candidates. Prior to Kadmon, Bryan received his PhD in Cell Biology from NYU Medical School of Medicine, and made important advances in ion channel and membrane protein structural biology. Prior to NYU, Bryan studied various oncogenes and tumor suppressors using biophysical methods at Memorial Sloan-Kettering Cancer Center.